Twist Bioscience is a leading synthetic biology company that accelerates drug discovery and development by decoding the code of life. The company leverages its proprietary silicon-based synthetic DNA manufacturing platform to produce high-quality genes, oligo pools, and variant libraries at scale.
Twist serves a broad range of applications in life sciences, including next-generation sequencing (NGS), antibody discovery, and biopharma development. Its products support researchers in genomics, agriculture, drug development, and diagnostics, enabling faster and more efficient scientific breakthroughs.
The company offers a comprehensive portfolio including NGS target enrichment panels, synthetic controls, library preparation kits, and antibody discovery solutions. Through its Twist Biopharma and antibody optimization services, it supports partners in developing therapeutic candidates with enhanced properties.